Eli Lilly Shares Down 7.5% as Market Reacts to Slashed Q4 Forecast

13 hours ago  · Shares of Eli Lilly are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for the fourth quarter of 2024.The pharmaceutical giant expects …


5%
OFF

Eli Lilly Shares Down 7.5% As Market Reacts To Slashed Q4 Forecast

2 weeks from now

13 hours ago  · Shares of Eli Lilly are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for the fourth quarter of 2024.The pharmaceutical giant expects …

yahoo.com

7%
OFF

Eli Lilly Stock Slumps On Lowered Sales Forecast - Yahoo Finance

2 weeks from now

10 hours ago  · Eli Lilly shares were down nearly 7% at $746 in intraday trading Tuesday following the news, though even with Tuesday's losses, they've gained over 17% in the last 12 months. …

yahoo.com

33%
OFF

Eli Lilly Shares Hit Yearly Low After Disappointing Q3 Earnings

2 weeks from now

Oct 31, 2024  · Still, Eli Lilly's shares today are still higher by 33% this year so far and by 590% for the past five years. Today's below-forecast results, though negative, demonstrate an …

yahoo.com

51%
OFF

Eli Lilly Cuts Sales Outlook After Sluggish Growth For Incretin Drugs

2 weeks from now

Eli Lilly LLY-7.51%decrease; red down pointing triangle cut its outlook for fourth-quarter revenue as the market for drugs that increase insulin levels grew slower than expected, but the …

wsj.com

6%
OFF

Eli Lilly Stock Tumbles After Drug Giant Misses Estimates And …

2 weeks from now

Oct 30, 2024  · The company's stock closed more than 6% lower on Wednesday. Eli Lilly now expects full-year adjusted earnings of between $13.02 and $13.52 per share, down from …

nbcwashington.com

6%
OFF

Eli Lilly Stock Sinks After Q3 Earnings Miss Wall Street Expectations

2 weeks from now

Eli Lilly missed Wall Street's revenue expectations in its third quarter earnings released Wednesday morning, which sent shares down more than 6%.The drugmaker also slashed its …

yahoo.com

61%
OFF

Why Eli Lilly Stock Is Sinking Today | The Motley Fool

2 weeks from now

Oct 30, 2024  · Shares of Eli Lilly (LLY 1.61%) were sinking 6.3% lower as of 11:11 a.m. ET on Wednesday. The sharp decline came after the big drugmaker announced its third-quarter …

fool.com

7%
OFF

Stock Market Today: Dow Pops, Nasdaq Slips As Focus Turns To CPI ...

2 weeks from now

9 hours ago  · Shares of Eli Lilly were a standout in the session, dropping over 7% and on track for their worst day since 2021 after the company said fourth quarter sales of its weight-loss drug …

yahoo.com

3%
OFF

Eli Lilly Plummets On Rare - Investor's Business Daily

2 weeks from now

Oct 30, 2024  · But on today's stock market, Eli Lilly stock plummeted 6.3% to 846 ... Eli Lilly cut its earnings target to $13.02 to $13.52 per share. The midpoint of Lilly's outlook missed analysts' …

investors.com

10%
OFF

Are Eli Lilly's Lowered Expectations A Reason To Sell?

2 weeks from now

Oct 31, 2024  · If there's one thing the stock market hates, it's unpredictability. Eli Lilly shares were down by more than 10% when the market opened on Wednesday and investors wonder if it …

nasdaq.com

6%
OFF

Eli Lilly Shares Drop As Drugmaker Cuts Revenue Guidance On …

2 weeks from now

14 hours ago  · The drugmaker's shares dropped about 6% in early trading Tuesday. Eli Lilly said it now expects full-year 2024 revenue of about $45 billion. That's lower than the $45.4 billion to …

nbcphiladelphia.com

6%
OFF

Why Did Eli Lilly Stock Fall 6%? - Nasdaq

2 weeks from now

Nov 1, 2024  · Eli Lilly stock (NYSE: LLY) fell over 6% on Wednesday, October 30, after it posted downbeat results. The company reported revenue of $11.4 billion and adjusted earnings of …

nasdaq.com

6%
OFF

Why Eli Lilly Stock Is Under Pressure Today - Nasdaq

2 weeks from now

Feb 2, 2023  · What happenedShares of Eli Lilly (NYSE: LLY) are tumbling Thursday morning. Specifically, the drugmaker's stock was down by a hefty 6.6% on heavy volume as of 11:15 …

nasdaq.com

$1.18
OFF

Eli Lilly Stock Crushed As Weight Loss Sales, Profits, Disappoint Wall ...

2 weeks from now

Oct 30, 2024  · Eli Lilly's bottom line of $1.18 per share was also south of Wall Street's $1.47 forecast, and the group lowered its full-year outlook to between $13.02 and $13.52 per share.

yahoo.com

FAQs about Eli Lilly Shares Down 7.5% as Market Reacts to Slashed Q4 Forecast Coupon?

Why did Eli Lilly lose $70 billion?

(Reuters) -Eli Lilly's high profile weight-loss and diabetes drugs fell short of Wall Street sales estimates on Wednesday as supplies sat in warehouses, a 180-degree turn for the company after long struggling to meet outsized demand. Lilly shares were off 8%, wiping out nearly $70 billion from the Indianapolis-based drugmaker's market value. ...

Why are Eli Lilly shares down 76% today?

Shares of Eli Lilly (NYSE:LLY) are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for the fourth quarter of 2024. The pharmaceutical giant expects only $13.5 billion in revenue for Q4 2024, compared to the consensus estimate of $13.97 billion. ...

Why did Eli Lilly stock crash Wednesday?

Eli Lilly (LLY) stock crashed Wednesday after the pharma giant cut its 2024 outlook following a "big" miss for its popular diabetes and weight-loss drugs. The company's drug, tirzepatide, provides the backbone for diabetes treatment Mounjaro and weight-loss drug Zepbound. In the September quarter, Mounjaro sales rocketed 121% to $3.11 billion. ...

What happened to Eli Lilly's stock valuation?

Eli Lilly's stock valuation sank by $100 billion Wednesday morning after the pharma giant reported third quarter earnings. ...

Why did Eli Lilly slash its profit guidance?

The disappointing performance was driven by lower-than-anticipated sales of the company's weight loss drug, Zepbound. Eli Lilly also slashed its profit guidance for the full year. ...

Why did Lilly stock drop 8%?

Lilly shares were off 8%, wiping out nearly $70 billion from the Indianapolis-based drugmaker's market value. Both its weight-loss drug Zepbound and diabetes treatment Mounjaro have been contending with high demand that has led to shortages, but last quarter Lilly said it had ramped up manufacturing and was able to fill back orders at wholesalers. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension